Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Pittsburgh Clinical Genomics Laboratory, |
RCV004784950 | SCV005397226 | uncertain significance | Vesicoureteral reflux 8 | 2022-08-23 | criteria provided, single submitter | clinical testing | This sequence variant is a single nucleotide substitution (C>T) at coding nucleotide 12677 of the TNXB gene which results in a threonine to methionine amino acid change at residue 4226 in the TNXB-encoded Tescin-X protein. This variant has not been reported in clinical genetics databases or observed in the medical literature in individuals with TNXB-related disease, to our knowledge. This variant is present in 3/177804 alleles (0.002%) in the gnomAD control population dataset, though population counts in this region may be iccurate due to pseudogene homology. The variant alters an amino acid in the tescin-X fibrinogen C-termil domain (Uniprot). Multiple bioinformatic tools predict that this variant is likely to be damaging, and threonine is highly conserved at this protein position in vertebrates. Functiol studies testing the effects of this variant have not been performed, to our knowledge. At this time, there is insufficient evidence to determine if this variant is pathogenic or benign. Therefore, we consider it to be a variant of uncertain significance. ACMG Criteria: PM2, PP3 |